 |
|
Home | Insider Buying: Kevin D. Freeman Buys 1,000 Shares of Galectin Therapeutics Stock (GALT) |
 |
Insider Buying: Kevin D. Freeman Buys 1,000 Shares of Galectin Therapeutics Stock (GALT)
|
 |
- August 19, 2014
-
Galectin Therapeutics (NASDAQ:GALT) Director Kevin D. Freeman purchased 1,000 shares of Galectin Therapeutics stock on the open market in a transaction that occurred on Friday, August 15th. The stock was purchased at an average cost of $4.70 per share, for a total transaction of $4,700.00. Following the completion of the acquisition, the director now directly […]This article (Insider Buying: Kevin D. Freeman Buys 1,000 Shares of Galectin Therapeutics Stock (GALT)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2014/08/18/insider-buying-kevin-d-freeman-buys-1000-shares-of-galectin-therapeutics-stock-galt-2/
|
 |
|
 |
|
 |
